<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="rickets-xlh" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">rickets-xlh</book-part-id>
      <title-group>
        <title>X-Linked Hypophosphatemia</title>
        <alt-title alt-title-type="alt-title">Synonyms: XLHR, X-Linked Hypophosphatemic Rickets, X-Linked Vitamin D-Resistant Rickets</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ruppe</surname>
            <given-names>Mary D</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>The Methodist Hospital<break/>Houston, Texas</aff>
          <email>mdruppe@houstonmethodist.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>9</day>
          <month>2</month>
          <year>2012</year>
        </date>
        <date date-type="updated">
          <day>13</day>
          <month>4</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>27</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="xlhi" document-type="chapter">X-Linked Hyper IgM Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="retinoschisis" document-type="chapter">X-Linked Juvenile Retinoschisis</related-object>
      <abstract id="rickets-xlh.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The phenotypic spectrum of X-linked hypophosphatemia (XLH) ranges from isolated hypophosphatemia to severe lower-extremity bowing. XLH frequently manifests in the first two years of life when lower-extremity bowing becomes evident with the onset of weight bearing; however, it sometimes is not manifest until adulthood, as previously unevaluated short stature. In adults, enthesopathy (calcification of the tendons, ligaments, and joint capsules) associated with joint pain and impaired mobility may be the initial presenting complaint. Persons with XLH are prone to spontaneous dental abscesses; sensorineural hearing loss has also been reported.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Low serum phosphate concentration and reduced tubular resorption of phosphate corrected for glomerular filtration rate (TmP/GFR) are characteristic. Additionally, the normal physiologic response to hypophosphatemia of an elevation of 1,25 (OH)<sub>2</sub> vitamin D is absent. Serum calcium and 25-hydroxy vitamin D are within the normal range; parathyroid hormone is normal to slightly elevated. Alkaline phosphatase is characteristically elevated in children, especially during periods of rapid growth, and usually returns to normal in adulthood with or without treatment. Identification of a hemizygous (in males) or heterozygous (in females) pathogenic variant in <italic toggle="yes">PHEX</italic> by molecular genetic testing confirms the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Pain and lower-extremity bowing improve with frequent oral administration of phosphate and high-dose calcitriol. Children are generally treated from the time of diagnosis until long bone growth is complete. The role of pharmacologic treatment in adults is less clear; such treatment is generally reserved for individuals with symptoms such as skeletal pain, upcoming orthopedic surgery, biochemical evidence of osteomalacia with an elevated alkaline phosphatase, or recurrent pseudofractures or stress fractures. Persistent lower-limb bowing and/or torsion resulting in misalignment of the lower extremity may require surgery.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Frequent oral administration of phosphate and high-dose calcitriol to minimize bowing of long bones during growth. Good oral hygiene with flossing, regular dental care, and active strategies to prevent dental abscesses.</p>
          <p><italic toggle="yes">Surveillance:</italic> For individuals on calcitriol and phosphate therapy:</p>
          <list list-type="bullet">
            <list-item>
              <p>Quarterly monitoring of serum concentrations of phosphate, calcium, creatinine, alkaline phosphatase, intact parathyroid hormone; and urinary calcium, phosphate, and creatinine for evidence of hyperparathyroidism and increased renal phosphate or calcium excretion</p>
            </list-item>
            <list-item>
              <p>Annual lower-extremity x-rays to assess skeletal response to treatment</p>
            </list-item>
            <list-item>
              <p>Periodic renal ultrasound examination to assess for nephrocalcinosis</p>
            </list-item>
            <list-item>
              <p>Dental follow up twice a year</p>
            </list-item>
          </list>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Treatment with phosphate without calcitriol because of the increased risk for hyperparathyroidism.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Molecular genetic testing (if the <italic toggle="yes">PHEX</italic> pathogenic variant has been identified in the family) or biochemical testing of infants at risk to ensure early treatment for optimal outcome.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> No data are available on the use of phosphate and calcitriol in pregnant women who have XLH. Most women with XLH who are on active therapy at the time of conception are continued on treatment throughout the pregnancy with vigilant monitoring of urinary calcium-to-creatinine ratios to detect hypercalciuria early in order to modify treatment accordingly.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>X-linked hypophosphatemia is inherited in an X-linked manner. An affected male passes the pathogenic variant to all his daughters and none of his sons; an affected female passes the pathogenic variant to 50% of her offspring. Offspring who inherit the pathogenic variant will be affected, but because of the great intrafamilial variation, severity cannot be predicted. Prenatal diagnosis for pregnancies at increased risk is possible if the <italic toggle="yes">PHEX</italic> pathogenic variant in the family has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="rickets-xlh.Diagnosis">
        <title>Diagnosis</title>
        <sec id="rickets-xlh.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>X-linked hypophosphatemia (XLH) <bold>should be suspected</bold> in an individual with the following clinical findings, radiographic findings, and results of biochemical testing. It should be noted that this is a dominant X-linked disorder in which males and females are similarly affected.</p>
          <sec id="rickets-xlh.Clinical">
            <title>Clinical</title>
            <p>Findings in children include progressive lower-extremity bowing with a decrease in height velocity after the child starts ambulating and the characteristic clinical signs of rickets: rachitic rosary, craniotabes, Harrison's groove (a horizontal channel at the lower end of the chest caused by the diaphragm pulling the osteomalacic bone inward), and epiphyseal swelling.</p>
            <p>Findings in adults include musculoskeletal complaints, stress fractures, dental abscesses, and/or the diagnosis of XLH in an offspring.</p>
          </sec>
          <sec id="rickets-xlh.Radiographic">
            <title>Radiographic</title>
            <p>In children the metaphyses may be widened, frayed, or cupped; sometimes rachitic rosary or beading of the ribs results from poor skeletal mineralization leading to overgrowth of the costochondral joint cartilage. Although involvement of the metaphyses of the lower limbs is typical, any metaphysis can be involved.</p>
          </sec>
          <sec id="rickets-xlh.Biochemical">
            <title>Biochemical</title>
            <p>The two main laboratory findings characteristic of XLH are low-serum phosphate concentration and reduced tubular resorption of phosphate corrected for glomerular filtration rate.</p>
            <p><bold>Low serum phosphate concentration.</bold> Normal phosphate concentrations vary with age, with higher values observed in infants; therefore, it is important to use the age-related values. One widely used data set is reviewed in <xref ref-type="table" rid="rickets-xlh.T.agebased_normal_serum_phos">Table 1</xref>. Several studies have reported the normative data for age-related serum phosphate values [reviewed by <xref ref-type="bibr" rid="rickets-xlh.REF.meites.1989">Meites 1989</xref>].</p>
            <table-wrap id="rickets-xlh.T.agebased_normal_serum_phos" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Age-Based Normal Serum Phosphate Reference Intervals</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age</th>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">mg/dL</th>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">mmol/L</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">0-5 days</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4.8-8.2</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1.55-2.65</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1-3 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3.8-6.5</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1.25-2.10</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4-11 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3.7-5.6</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1.20-1.80</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">12-15 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2.9-5.4</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0.95-1.75</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;15 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2.7-4.7</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_serum_phos_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0.90-1.50</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>
                    <xref ref-type="bibr" rid="rickets-xlh.REF.lockitch.1988.1622">Lockitch et al [1988]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Reduced tubular resorption of phosphate corrected for glomerular filtration rate (TmP/GFR).</bold> Historically, the calculation of TmP/GFR has relied on the nomogram-based method described by <xref ref-type="bibr" rid="rickets-xlh.REF.walton.1975.309">Walton &#x00026; Bijvoet [1975]</xref> (<xref ref-type="fig" rid="rickets-xlh.F1">Figure 1</xref>).</p>
            <p>In order to use the nomogram, the tubular resorption of phosphate (TRP) must first be calculated as follows:</p>
            <list list-type="bullet">
              <list-item>
                <p>TRP = 1- [(urine<sub>phosphate</sub>/ plasma<sub>phosphate</sub>)/(urine<sub>creatinine</sub>/plasma<sub>creatinine</sub>)]</p>
              </list-item>
            </list>
            <p>When the TRP is less than 0.86, the TmP/GFR can be calculated directly as follows:</p>
            <list list-type="bullet">
              <list-item>
                <p>TmP/GFR = TRP x Plasma<sub>phosphate</sub></p>
              </list-item>
            </list>
            <p>The age-related reference ranges for the TmP/GFR are shown in <xref ref-type="table" rid="rickets-xlh.T.agebased_normal_tmpgfr_ref">Table 2</xref> [<xref ref-type="bibr" rid="rickets-xlh.REF.payne.1998.201">Payne 1998</xref>].</p>
            <table-wrap id="rickets-xlh.T.agebased_normal_tmpgfr_ref" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Age-Based Normal TmP/GFR Reference Intervals</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age</th>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sex</th>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Range (mg/dL)</th>
                    <th id="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Range (mmol/L)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Birth</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Both</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3.6 - 8.6</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1.43 - 3.43</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">3 mos</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Both</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3.7 - 8.25</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1.48 - 3.30</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">6 mos</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Both</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.9 - 6.5</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1.15 - 2.60</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">2-15 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Both</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.9 - 6.5</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1.15 - 2.44</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">25-35 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Male</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.5 - 3.4</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1.00 - 1.35</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">25-35 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Female</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.4 - 3.6</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0.96 - 1.44</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">45-55 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Male</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.2 - 3.4</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0.90 - 1.35</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">45-55 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Female</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.2 - 3.6</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0.88 - 1.42</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">65-75 yrs</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Both</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2.0 - 3.4</td>
                    <td headers="hd_h_rickets-xlh.T.agebased_normal_tmpgfr_ref_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0.80 - 1.35</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>
                    <xref ref-type="bibr" rid="rickets-xlh.REF.payne.1998.201">Payne [1998]</xref>
                  </p>
                </fn>
                <fn>
                  <p>Note: For the calculation of the TRP the urine should be collected as an untimed urine after an overnight fast.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Other suggestive laboratory findings</bold> include:</p>
            <list list-type="bullet">
              <list-item>
                <p>Normal serum calcium and 25-hydroxyvitamin D [25(OH)D]. Note: If the serum 25(OH)D concentration is low, vitamin D levels need to be replete before the diagnosis of XLH can be confirmed by laboratory testing.</p>
              </list-item>
              <list-item>
                <p>Inappropriately normal serum calcitriol concentration in the presence of hypophosphatemia</p>
              </list-item>
              <list-item>
                <p>Normal parathyroid hormone level; however, it may be minimally elevated in some individuals.</p>
              </list-item>
              <list-item>
                <p>Absence of glycosuria, bicarbonaturia, proteinuria, or amino aciduria</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="rickets-xlh.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of XLH <bold>is established</bold> in a proband with low serum phosphate concentration, a reduced TmP/GFR based on normative values for age, an inappropriate level of calcitriol for the level of hypophosphatemia, and/or by identification on molecular genetic testing of:</p>
          <list list-type="bullet">
            <list-item>
              <p>A hemizygous <italic toggle="yes">PHEX</italic> pathogenic variant in a male proband; or</p>
            </list-item>
            <list-item>
              <p>A heterozygous <italic toggle="yes">PHEX</italic> pathogenic variant in a female proband.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="table" rid="rickets-xlh.T.agebased_normal_serum_phos">Table 1</xref>.</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">PHEX</italic> is performed first and followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">PHEX</italic> and other genes of interest (see <xref ref-type="sec" rid="rickets-xlh.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="rickets-xlh.T.molecular_genetic_testing" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Molecular Genetic Testing Used in X-Linked Hypophosphatemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">PHEX</italic>
                  </td>
                  <td headers="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">57%-78%&#x000a0;<sup>5,&#x000a0;6,&#x000a0;7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_rickets-xlh.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">22%-43%&#x000a0;<sup>5,&#x000a0;7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rickets-xlh.TF.3.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rickets-xlh" object-id="rickets-xlh.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="rickets-xlh.TF.3.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="rickets-xlh.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="rickets-xlh.TF.3.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="rickets-xlh.TF.3.4">
                <label>4. </label>
                <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation requires additional testing by gene-targeted deletion/duplication analysis.</p>
              </fn>
              <fn id="rickets-xlh.TF.3.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="rickets-xlh.REF.morey.2011.116">Morey et al [2011]</xref>
                </p>
              </fn>
              <fn id="rickets-xlh.TF.3.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="rickets-xlh.REF.holm.1997.790">Holm et al [1997]</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.dixon.1998.3615">Dixon et al [1998]</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.ichikawa.2008.663">Ichikawa et al [2008]</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.gaucher.2009.401">Gaucher et al [2009]</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.ruppe.2011.312">Ruppe et al [2011]</xref>. Some of the reports suggest a lower rate of variant detection in simplex cases (i.e., a single occurrence in a family); however, this has not been clearly documented.</p>
              </fn>
              <fn id="rickets-xlh.TF.3.7">
                <label>7. </label>
                <p>Two studies utilized multiplex ligation-dependent probe amplification (MLPA) to detect deletions and duplications [<xref ref-type="bibr" rid="rickets-xlh.REF.clausmeyer.2009.211">Clausmeyer et al 2009</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.morey.2011.116">Morey et al 2011</xref>]. Of note, using both exon sequencing and MLPA analysis, <xref ref-type="bibr" rid="rickets-xlh.REF.morey.2011.116">Morey et al [2011]</xref> detected pathogenic variants in 100% of their cohort of 36 unrelated families. In contrast, the Clausmeyer study (which also utilized both techniques) failed to find a pathogenic variant in a subset of individuals tested.</p>
              </fn>
              <fn id="rickets-xlh.TF.3.8">
                <label>8. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="rickets-xlh.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="rickets-xlh.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical presentation of X-linked hypophosphatemia (XLH) ranges from isolated hypophosphatemia to severe lower-extremity bowing. The diagnosis is frequently made in the first two years of life when lower-extremity bowing becomes evident with the onset of weight bearing; however, because of the extremely variable presentation, the diagnosis is sometimes not made until adulthood.</p>
          <sec id="rickets-xlh.Skeletal_Abnormalities">
            <title>Skeletal Abnormalities</title>
            <p>Individuals with XLH commonly present with short stature and lower-extremity bowing (valgus or varus deformities). Joint pain and impaired mobility associated with enthesopathy, osteophyte formation or other radiologic findings can occur.</p>
            <p>
              <bold>Short stature</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Adults with XLH have a significantly reduced final height with a standard deviation score (SDS) of -1.9 compared to reference standards. Individuals appear disproportionate, with leg length scores (-2.7) being significantly lower than those for sitting height (-1.1) [<xref ref-type="bibr" rid="rickets-xlh.REF.becknielsen.2010.108">Beck-Nielsen et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>In a longitudinal study that assessed growth in children prior to and during treatment, <xref ref-type="bibr" rid="rickets-xlh.REF.zivi_njak.2011.223">Zivi&#x0010d;njak et al [2011]</xref> found that untreated children had disproportionate total height (-2.48 SDS) to sitting height (-0.99 SDS); lower leg length was -2.90 SDS. During treatment there was an uncoupling of growth between the trunk and the legs: the difference between SDS sitting and lower leg length became more pronounced as the subjects grew.</p>
              </list-item>
            </list>
            <p>
              <bold>Lower extremity bowing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Genu varum (outward bowing of the lower leg) or genu valgus (inward bowing) can occur.</p>
              </list-item>
              <list-item>
                <p>Lower extremity torsion and rotation may also be seen.</p>
              </list-item>
            </list>
            <p>
              <bold>Joint pain and impaired mobility</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>In adults, calcification of the tendons, ligaments, and joint capsules, known as enthesopathy, can cause joint pain and impair mobility [<xref ref-type="bibr" rid="rickets-xlh.REF.polisson.1985.1">Polisson et al 1985</xref>].</p>
              </list-item>
              <list-item>
                <p>Enthesopathy of vertebral ligaments has been reported [<xref ref-type="bibr" rid="rickets-xlh.REF.becknielsen.2010.108">Beck-Nielsen et al 2010</xref>], including a case report of spinal cord compression and paraplegia following calcification of the ligamenta flava [<xref ref-type="bibr" rid="rickets-xlh.REF.vera.1997.710">Vera et al 1997</xref>].</p>
              </list-item>
              <list-item>
                <p>Increased osteophyte formation with spinal hyperostosis and arthritis or fusion of the sacroiliac joints can also lead to pain and compromised mobility.</p>
              </list-item>
              <list-item>
                <p>A radiologic survey of 38 untreated adults revealed flaring of the iliac wings, trapezoidal distal femoral condyles, shortening of the talar neck, and flattening of the talar dome [<xref ref-type="bibr" rid="rickets-xlh.REF.hardy.1989.403">Hardy et al 1989</xref>]. Looser's zone or pseudofractures that may be symptomatic or asymptomatic were commonly seen and have been reported to occur at any age.</p>
              </list-item>
            </list>
          </sec>
          <sec id="rickets-xlh.Cranial_Structures">
            <title>Cranial Structures</title>
            <p>Cranial abnormalities include frontal bossing, craniosynostosis, and Chiari malformations. A detailed cephalometric study revealed increased head length, decreased occipital breadth, and a low mean cephalic index (the ratio of the maximum width of the head multiplied by 100 divided by its maximum length) [<xref ref-type="bibr" rid="rickets-xlh.REF.pronicka.2004.141">Pronicka et al 2004</xref>]. The incidence of Chiari malformations, which may cause headache and vertigo, has not been determined.</p>
          </sec>
          <sec id="rickets-xlh.Dental_Abnormalities">
            <title>Dental Abnormalities</title>
            <p>Persons with XLH are prone to spontaneous dental abscesses, which have been attributed to changes in the dentin component of teeth: irregular spaces with defective mineralization in the tooth dentin have been described [<xref ref-type="bibr" rid="rickets-xlh.REF.boukpessi.2006.294">Boukpessi et al 2006</xref>]; panoramic imaging reveals enlarged pulp chambers with prominent pulp horns leading to susceptibility to abscess formation [<xref ref-type="bibr" rid="rickets-xlh.REF.baroncelli.2006.61">Baroncelli et al 2006</xref>].</p>
          </sec>
          <sec id="rickets-xlh.Hearing_Loss">
            <title>Hearing Loss</title>
            <p>Sensorineural hearing loss has been reported; the actual prevalence of hearing loss is not known. Radiographic evaluation of a small number of persons with XLH and hearing loss showed generalized osteosclerosis and thickening of the petrous bone [<xref ref-type="bibr" rid="rickets-xlh.REF.omalley.1988.528">O'Malley et al 1988</xref>], a finding that has not been evaluated in other cohorts.</p>
          </sec>
          <sec id="rickets-xlh.Differences_in_Manifestation">
            <title>Differences in Manifestations in Males and Females</title>
            <p>The features of X-linked hypophosphatemia are the same in males and females. The severity can differ among members of the same family. The etiology of this variability within the same cohort is not known.</p>
          </sec>
        </sec>
        <sec id="rickets-xlh.GenotypePhenotype_Correlatio">
          <title>Genotype-Phenotype Correlations</title>
          <p>Several studies have evaluated genotype-phenotype correlations in XLH.</p>
          <list list-type="bullet">
            <list-item>
              <p>The largest study, involving 59 persons, correlated dental and hearing defects with pathogenic variants in exons near the 5' (or beginning) of the gene and increased head length with pathogenic variants in exons near the end of the gene [<xref ref-type="bibr" rid="rickets-xlh.REF.popowska.2001.73">Popowska et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>Two studies suggested a correlation between more severe bone disease (defined by the severity of bowing and a history of osteotomies) and truncating variants [<xref ref-type="bibr" rid="rickets-xlh.REF.holm.2001.3889">Holm et al 2001</xref>] or pathogenic variants in the C-terminal portion of <italic toggle="yes">PHEX</italic> [<xref ref-type="bibr" rid="rickets-xlh.REF.song.2007.981">Song et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>A study by <xref ref-type="bibr" rid="rickets-xlh.REF.morey.2011.116">Morey et al [2011]</xref> showed that clearly deleterious <italic toggle="yes">PHEX</italic> pathogenic variants (nonsense variants, insertions or deletions, and splice site variants leading to premature stop codons) had lower tubular resorption of phosphate and lower calcitriol levels than did plausibly deleterious variants (missense changes or in-frame deletions).</p>
            </list-item>
          </list>
        </sec>
        <sec id="rickets-xlh.Penetrance">
          <title>Penetrance</title>
          <p>Despite a wide degree of clinical variability in XLH, penetrance is often said to be 100% by age one year [<xref ref-type="bibr" rid="rickets-xlh.REF.sabbagh.2014">Sabbagh et al 2014</xref>]. There is no known difference between penetrance in males and females.</p>
          <p>One instance of discordance for XLH in monozygotic twin girls was reported by <xref ref-type="bibr" rid="rickets-xlh.REF.owen.2009.237">Owen et al [2009]</xref>: at age 19 months the girls were diagnosed with XLH based on biochemical findings and family history; no <italic toggle="yes">PHEX</italic> pathogenic variant was identified in either twin. One twin was significantly shorter than the other (length: -1.3 vs -0.4 SD). The shorter twin had marked bilateral genu varum; the other twin had mild genu valgum. The authors proposed that non-penetrance resulted from discordant X-chromosome inactivation with non-random lack of <italic toggle="yes">PHEX</italic> expression in critical tissues.</p>
        </sec>
        <sec id="rickets-xlh.Nomenclature">
          <title>Nomenclature</title>
          <p>X-linked hypophosphatemia (or its common abbreviation, XLH) is the current and preferable term. Other terms that have been used:</p>
          <list list-type="bullet">
            <list-item>
              <p>X-linked hypophosphatemic rickets (XLH)</p>
            </list-item>
            <list-item>
              <p>Hypophosphatemic rickets</p>
            </list-item>
            <list-item>
              <p>X-linked dominant hypophosphatemic rickets (XLHR)</p>
            </list-item>
            <list-item>
              <p>X-linked rickets (XLR)</p>
            </list-item>
            <list-item>
              <p>Vitamin D-resistant rickets</p>
            </list-item>
            <list-item>
              <p>X-linked vitamin D-resistant rickets (VDRR)</p>
            </list-item>
            <list-item>
              <p>Hypophosphatemic vitamin D-resistant rickets (HPDR)</p>
            </list-item>
            <list-item>
              <p>Phosphate diabetes</p>
            </list-item>
            <list-item>
              <p>Familial hypophosphatemic rickets</p>
            </list-item>
          </list>
        </sec>
        <sec id="rickets-xlh.Prevalence">
          <title>Prevalence</title>
          <p>The incidence of XLH is 3.9-5 per 100,000 live births [<xref ref-type="bibr" rid="rickets-xlh.REF.davies.1981.595">Davies &#x00026; Stanbury 1981</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.becknielsen.2009.491">Beck-Nielsen et al 2009</xref>].</p>
        </sec>
      </sec>
      <sec id="rickets-xlh.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">PHEX</italic>.</p>
      </sec>
      <sec id="rickets-xlh.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The rachitic skeletal changes of nutritional and hereditary forms of rickets are indistinguishable. These types of rickets can be distinguished by biochemical testing: in hypophosphatemic rickets, serum concentrations of 25-hydroxy vitamin D and calcium are normal, whereas in vitamin D-deficient rickets the 25-hydroxy vitamin D serum concentration is low and the calcium concentration may be low or normal. The different forms of hypophosphatemic rickets are distinguished by the presence of hypercalciuria or elevated 1,25(OH)2D. Mode of inheritance and molecular genetic testing help distinguish the different forms of hereditary hypophosphatemic rickets without hypercalciuria (of which XLH is the most common).</p>
        <table-wrap id="rickets-xlh.T.other_genetic_and_acquired" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p>Other Genetic and Acquired Disorders of Renal Phosphate Wasting</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1">Differential Diagnosis Disorder</th>
                <th id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2">Gene(s)</th>
                <th id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3">MOI</th>
                <th id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features of This Disorder</th>
                <th id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5">Pathogenesis of Differential Diagnosis Disorder</th>
              </tr>
              <tr>
                <th headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4" id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping with XLH</th>
                <th headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4" id="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing from XLH</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">AD hypophosphatemic rickets (ADHR)<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/193100">193100</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FGF23</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Renal phosphate wasting w/out hypercalciuria</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">ADHR is much rarer than XLH. Onset of ADHR can be delayed; rarely, phosphate wasting resolves later in life&#x000a0;<sup>1</sup>.</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">ADHR results in the stabilization of the full-length active form of the protein leading to prolonged or enhanced FGF23 action.</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">AR hypophosphatemic rickets<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/241520">241520</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613312">613312</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">DMP1</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">ENPP1</italic>&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Renal phosphate wasting w/out hypercalciuria</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Extremely rare</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Tumor-induced osteomalacia (TIO) (oncogenic osteomalacia)&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Renal phosphate wasting w/out hypercalciuria; skeletal deformities &#x00026; growth restriction in children; progressive muscle &#x00026; bone pain in adults</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">The majority of individuals w/TIO are adults (although onset can occur at any age); acquired form of hypophosphatemia.</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Secretion of FGF23 by slow-growing mesenchymal tumors known as 'phosphaturic mesenchymal tumors, mixed connective tissue type'</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="mccune-albright" document-type="chapter">McCune-Albright syndrome</related-object>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GNAS</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 7</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypophosphatemic rickets</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Fibrous dysplasia of the bone; precocious puberty; caf&#x000e9; au lait lesions</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Overproduction of FGF23 by the fibrous dysplastic bone resulting in renal phosphate wasting&#x000a0;<sup>6</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cutaneous skeletal hypophosphatemia syndrome&#x000a0;<sup>8</sup><break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/163200">163200</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">HRAS</italic>
                  <break/>
                  <italic toggle="yes">KRAS</italic>
                  <break/>
                  <italic toggle="yes">NRAS</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 7</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypophosphatemia is frequent &#x00026; biochemically indistinguishable from that seen in XLH.</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple cutaneous nevi; radiologic evidence of fibrous dysplasia</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">FGF23 is the cause of the phosphate wasting&#x000a0;<sup>9</sup>.</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hereditary hypophosphatemic rickets with hypercalciuria<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/241530">241530</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SLC34A3</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" rowspan="3" valign="middle" align="left" colspan="1">Hypophosphatemia; hypercalciuria</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" rowspan="3" valign="middle" align="left" colspan="1">Increased 1,25(OH)<sub>2</sub> vitamin (not associated w/the inappropriately normal 1,25(OH)<sub>2</sub> vitamin D seen in XLH)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" rowspan="3" valign="middle" align="left" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypophosphatemic nephrolithiasis/osteoporosis<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS612286">PS612286</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SLC34A1</italic>
                  <break/>
                  <italic toggle="yes">SLC9A3R1</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypophosphatemic rickets, X-linked recessive<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/300554">300554</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">CLCN5</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Fanconi syndrome<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS134600">PS134600</ext-link>)</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 10</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 10</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Renal phosphate loss</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Presence of glycosuria, bicarbonaturia, and/or amino aciduria</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Proximal renal tubule transport of many different substances can be impaired.</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Nutritional forms of rickets</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Not<break/>applicable</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not applicable</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Rachitic skeletal changes of nutritional &#x00026; hereditary forms of rickets are clinically indistinguishable.</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">In vitamin D-deficient rickets:<break/>25-hydroxy vitamin D serum concentration is low; calcium concentration may be low or normal.</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Raine syndrome&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FAM20C</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Osteosclerotic skeletal changes; hypophosphatemia</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Severe form is neonatal lethal. Milder form is associated w/hypophosphatemia.</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Decreased DMP1 activity leads to increased FGF23 production.</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Osteoglophonic dysplasia&#x000a0;<sup>12</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FGFR1</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypophosphatemia; lower than expected calcitriol levels</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Hypophosphatemia; lower than expected calcitriol levels</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Increased FGF23 production from abnormal bone</td>
              </tr>
              <tr>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypophosphatemia rickets with hyperparathyroidism&#x000a0;<sup>13</sup></td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">KL</italic>
                </td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypophosphatemia; inappropriately normal calcitriol level</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_4 hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Hyperparathyroidism</td>
                <td headers="hd_h_rickets-xlh.T.other_genetic_and_acquired_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Increased alpha-KLOTHO &#x00026; increased FGF23</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>XL = X-linked</p>
            </fn>
            <fn>
              <p>NA = not applicable</p>
            </fn>
            <fn id="rickets-xlh.TF.4.1">
              <label>1. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.econs.1997.674">Econs &#x00026; McEnery [1997]</xref>
              </p>
            </fn>
            <fn id="rickets-xlh.TF.4.2">
              <label>2. </label>
              <p><xref ref-type="bibr" rid="rickets-xlh.REF.feng.2006.1310">Feng et al [2006]</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.lorenzdepiereux.2006.1248">Lorenz-Depiereux et al [2006]</xref></p>
            </fn>
            <fn id="rickets-xlh.TF.4.3">
              <label>3. </label>
              <p><xref ref-type="bibr" rid="rickets-xlh.REF.levylitan.2010.273">Levy-Litan et al [2010]</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.lorenzdepiereux.2010.267">Lorenz-Depiereux et al [2010]</xref></p>
            </fn>
            <fn id="rickets-xlh.TF.4.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.folpe.2004.1">Folpe et al [2004]</xref>
              </p>
            </fn>
            <fn id="rickets-xlh.TF.4.5">
              <label>5. </label>
              <p>Tumor-induced osteomalacia is a paraneoplastic syndrome.</p>
            </fn>
            <fn id="rickets-xlh.TF.4.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.riminucci.2003.683">Riminucci et al [2003]</xref>
              </p>
            </fn>
            <fn id="rickets-xlh.TF.4.7">
              <label>7. </label>
              <p>Caused by postzygotic somatic activating variant in <italic toggle="yes">GNAS</italic></p>
            </fn>
            <fn id="rickets-xlh.TF.4.8">
              <label>8. </label>
              <p>Previously referred to as linear sebaceous nevus syndrome or epidermal nevus syndrome</p>
            </fn>
            <fn id="rickets-xlh.TF.4.9">
              <label>9. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.hoffman.2005.233">Hoffman et al [2005]</xref>
              </p>
            </fn>
            <fn id="rickets-xlh.TF.4.10">
              <label>10. </label>
              <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS134600">OMIM Phenotypic Series: Fanconi renotubular syndrome</ext-link> and related OMIM entries to view associated genes (and information about MOI).</p>
            </fn>
            <fn id="rickets-xlh.TF.4.11">
              <label>11. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.kinoshita.2014.145">Kinoshita et al [2014]</xref>
              </p>
            </fn>
            <fn id="rickets-xlh.TF.4.12">
              <label>12. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.white.2005.361">White et al [2005]</xref>
              </p>
            </fn>
            <fn id="rickets-xlh.TF.4.13">
              <label>13. </label>
              <p>
                <xref ref-type="bibr" rid="rickets-xlh.REF.brownstein.2008.3455">Brownstein et al [2008]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="rickets-xlh.Management">
        <title>Management</title>
        <sec id="rickets-xlh.Evaluations_Following_Initia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with X-linked hypophosphatemia (XLH), the following evaluations are recommended.</p>
          <p>
            <bold>Children</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A lower-extremity x-ray (teleoroentgenogram), and x-ray of the wrists to assess the extent of skeletal disease</p>
            </list-item>
            <list-item>
              <p>Bone age measurement to evaluate growth potential</p>
            </list-item>
            <list-item>
              <p>Craniofacial examination for signs of craniosynostosis</p>
            </list-item>
            <list-item>
              <p>Dental examination</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation</p>
            </list-item>
          </list>
          <p>
            <bold>Adults</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>X-ray of skeletal sites with reported pain to assess for possible enthesopathy or stress fractures</p>
            </list-item>
            <list-item>
              <p>Dental examination</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation</p>
            </list-item>
          </list>
          <p>
            <bold>Individuals of any age</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation of those with headache and vertigo for Chiari malformation</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="rickets-xlh.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Pharmacologic treatment</bold> focuses on improving pain and correcting bone deformation.</p>
          <p>In <bold>children</bold>, treatment generally begins at the time of diagnosis and continues until long bone growth is complete.</p>
          <p>Treatment for most children consists of oral phosphate administered three to five times daily and high-dose calcitriol, the active form of vitamin D. Two different regimens have been used, but have not been compared:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Low dose.</bold> Treatment is generally started at a low dose to avoid the gastrointestinal side effects of diarrhea and gastrointestinal upset. The doses are then titrated to a weight-based dose of calcitriol at 20 to 30 ng/kg/day administered in two to three divided doses and phosphate at 20 to 40 mg/kg/day administered in three to five divided doses [<xref ref-type="bibr" rid="rickets-xlh.REF.carpenter.2011.1381">Carpenter et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>High dose.</bold> Some clinicians favor a high-dose phase of treatment for up to a year. The high-dose phase consists of calcitriol at 50-70 ng/kg/day (up to a maximum dose of 3.0 &#x000b5;g daily) along with the phosphate [<xref ref-type="bibr" rid="rickets-xlh.REF.sabbagh.2014">Sabbagh et al 2014</xref>].</p>
            </list-item>
          </list>
          <p>Doses are adjusted based on (1) evidence of therapeutic success including reduction in serum alkaline phosphatase activity, changes in musculoskeletal examination, improvement in radiographic rachitic changes, and (when possible) improved growth velocity; and (2) evidence of therapeutic complications including hyperparathyroidism, hypercalciuria, and nephrocalcinosis (see <xref ref-type="sec" rid="rickets-xlh.Prevention_of_Secondary_Comp">Prevention of Secondary Complications</xref>). Note: Normalization of the serum phosphate concentration is not a therapeutic goal as normal serum phosphate concentration frequently indicates overtreatment and increases the risk for treatment-related complications.</p>
          <p><xref ref-type="bibr" rid="rickets-xlh.REF.jehan.2008.4672">Jehan et al [2008]</xref> described differences in growth during treatment that are associated with different vitamin D receptor promoter haplotypes, providing a possible explanation for some of the clinical variability observed in XLH.</p>
          <p>After growth is complete, lower doses of the medications can be used to reach the treatment goals.</p>
          <p>In <bold>adults</bold>, the role of treatment has not been well studied; treatment is generally reserved for individuals with symptoms such as skeletal pain, upcoming orthopedic surgery, biochemical evidence of osteomalacia with an elevated alkaline phosphatase, or recurrent pseudofractures or stress fractures [<xref ref-type="bibr" rid="rickets-xlh.REF.carpenter.2011.1381">Carpenter et al 2011</xref>]. The calcitriol doses that are frequently employed in adults are in the range of 0.50 to 0.75 &#x000b5;g daily; the phosphate is given as 750 to 1000 mg/day in three to four divided doses. As with children, the phosphate dose is slowly titrated to avoid gastrointestinal side effects, starting at 250 mg/day and titrating up by 250 mg/day each week until the final dose is reached.</p>
          <p><bold>Orthopedic treatment.</bold> Despite what appears to be adequate pharmacologic therapy (see following Note), some individuals have persistent lower-limb bowing and torsion, which may lead to misalignment of the lower extremity. In these individuals, surgical treatment is frequently pursued. No control trials of the different surgical techniques have been undertaken; the literature consists of case series. Note: Poor compliance with pharmacologic therapy during childhood and the teen years may be one factor for persistent lower-limb deformities.</p>
          <p>In prepubertal children who have not yet reached their peak growth velocity (generally before age 10 years), stapling or toggle plate insertion can be considered as a minimally invasive method of reversible hemi-epiphysiodesis [<xref ref-type="bibr" rid="rickets-xlh.REF.novais.2006.238">Novais &#x00026; Stevens 2006</xref>]. Note: The risk with this procedure is prematurely stopping growth.</p>
          <p>In older children and adults, surgical techniques reported include distraction osteogenesis by external fixation, acute correction by external fixation with intramedullary nailing, internal fixation with intramedullary nailing, and acute correction by intramedullary nailing [<xref ref-type="bibr" rid="rickets-xlh.REF.song.2006.307">Song et al 2006</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.petje.2008.3078">Petje et al 2008</xref>].</p>
          <p>Additionally, total hip and knee arthroplasty is sometimes required because of degenerative joint disease and enthesopathy. Treatment in adults has not been shown to influence enthesopathy [<xref ref-type="bibr" rid="rickets-xlh.REF.connor.2015.3625">Connor et al 2015</xref>].</p>
          <p><bold>Craniofacial treatment.</bold> Although hypophosphatemic rickets is a rare condition, a recent review from three neurosurgical centers reported on ten patients treated over twenty years and recommended prompt referral to a craniofacial specialist when head shape abnormalities are seen in patients with this disorder [<xref ref-type="bibr" rid="rickets-xlh.REF.vega.2016.694">Vega et al 2016</xref>].</p>
          <p><bold>Dental treatment.</bold> Because individuals with XLH are susceptible to recurrent dental abscesses which may result in premature loss of decidual and permanent teeth, good oral hygiene with flossing and regular dental care and fluoride treatments are the cornerstones of prevention. Pit and fissure sealants have been recommended but have not been well studied. A recent study has suggested that treatment of adults with phosphate and calcitriol can improve the severity of dental disease [<xref ref-type="bibr" rid="rickets-xlh.REF.connor.2015.3625">Connor et al 2015</xref>].</p>
          <p><bold>Sensorineural hearing loss</bold> has been reported in persons with XLH; individuals with this complication are treated in a standard manner. See <related-object source-id="gene" document-id="deafness-overview" object-id="deafness-overview.Management">Hereditary Hearing Loss and Deafness Overview, Management</related-object>.</p>
        </sec>
        <sec id="rickets-xlh.Prevention_of_Primary_Manife">
          <title>Prevention of Primary Manifestations</title>
          <p>See <xref ref-type="sec" rid="rickets-xlh.Treatment_of_Manifestations">Treatment of Manifestations</xref>, <bold>Pharmacologic treatment</bold>.</p>
        </sec>
        <sec id="rickets-xlh.Prevention_of_Secondary_Comp">
          <title>Prevention of Secondary Complications</title>
          <p><bold>Hyperparathyroidism</bold> is associated with treatment for XLH. Rarely, hyperparathyroidism is present at the time of diagnosis; most often it occurs secondary to high phosphate doses and may proceed to tertiary hyperparathyroidism. In order to monitor for these complications, intact parathyroid hormone, serum calcium concentrations, and TmP/GFR should be measured quarterly (see <xref ref-type="sec" rid="rickets-xlh.Surveillance">Surveillance</xref>).</p>
          <p>If secondary hyperparathyroidism is identified, either the calcitriol dose may be increased or the phosphate dose decreased. A small clinical trial and several case reports have investigated the use of cinacalcet in adults with XLH who have secondary hyperparathyroidism [<xref ref-type="bibr" rid="rickets-xlh.REF.alon.2008.658">Alon et al 2008</xref>]. No long-term studies have been conducted. The clinical trial (comprising 8 individuals ages 6-19) involved in-patient monitoring of phosphate, iPTH, and Tmp/GFR after a single dose of cinacalcet; results showed a decrease in iPTH and an increase in phosphate and TmP/GFR.</p>
          <p>If tertiary hyperparathyroidism is identified, surgical evaluation is warranted.</p>
          <p><bold>Hypercalcemia and hypercalciuria</bold> may also complicate long-term treatment for XLH and is associated with high calcitriol doses. Serum calcium concentrations and urine calcium/creatinine ratio should be monitored quarterly (see <xref ref-type="sec" rid="rickets-xlh.Surveillance">Surveillance</xref>). If hypercalcemia or hypercalciuria is detected, the calcitriol dose should be decreased.</p>
          <p><bold>Nephrocalcinosis,</bold> reported in persons medically treated for XLH, may occur independent of hypercalcemia and hypercalciuria detected on laboratory evaluation. A baseline renal ultrasound examination should be performed at the start of treatment. The frequency of renal ultrasound examination to monitor for the development of nephrocalcinosis is not established; one- to five-year intervals have been recommended [<xref ref-type="bibr" rid="rickets-xlh.REF.carpenter.2011.1381">Carpenter et al 2011</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.sabbagh.2014">Sabbagh et al 2014</xref>].</p>
        </sec>
        <sec id="rickets-xlh.Surveillance">
          <title>Surveillance</title>
          <p>Periodic clinical evaluation to assess for disease progression, treatment response, and therapeutic complications is indicated.</p>
          <p>For individuals on calcitriol and phosphate therapy the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Quarterly monitoring of the following: serum concentrations of phosphate, calcium, and creatinine; alkaline phosphatase level; intact parathyroid hormone level; and urinary calcium, phosphate, and creatinine to identify and thus prevent therapeutic complications</p>
            </list-item>
            <list-item>
              <p>Intermittent monitoring of lower-extremity x-rays (teleoroentgenograms) to assess skeletal response to treatment. The frequency has not been well established; although annual imaging can be considered, the decision for imaging should be based on symptoms and physical examination findings.</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination to assess for nephrocalcinosis. The frequency has not been well established.</p>
            </list-item>
            <list-item>
              <p>Dental follow up twice a year (as for children and teenagers at high risk for caries)</p>
            </list-item>
          </list>
        </sec>
        <sec id="rickets-xlh.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>It is recommended that treatment with unopposed phosphate (without 1,25(OH)<sub>2</sub> vitamin D) be avoided as this is felt to increase the risk for hyperparathyroidism.</p>
          <p>Although 1,25(OH)<sub>2</sub> vitamin D has been used as a single agent, this use is felt to increase the risk for hypercalcemia, hypercalciuria, and nephrocalcinosis.</p>
        </sec>
        <sec id="rickets-xlh.Evaluation_of_Relatives_at_R">
          <title>Evaluation of Relatives at Risk</title>
          <p>Testing of at-risk infants and children is warranted to ensure early diagnosis and early treatment for optimal outcome.</p>
          <p>Evaluation can be accomplished by:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the <italic toggle="yes">PHEX</italic> pathogenic variant has been identified in an affected family member;</p>
            </list-item>
            <list-item>
              <p>Biochemical testing consisting of serum phosphorus, creatinine, calcium, alkaline phosphatase, intact parathyroid hormone, 25-hydroxy vitamin D [25(OH)D], and 1,25(OH)<sub>2</sub> vitamin D concentrations and urine phosphorus and creatinine concentrations. Infants with initially normal test results require reevaluation every two to three months until at least age one year.</p>
            </list-item>
            <list-item>
              <p>No role has been established for screening asymptomatic adult family members.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="rickets-xlh.Related_Genetic_Counseling_I">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="rickets-xlh.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>No data on the use of phosphate and calcitriol in pregnant women with XLH are available. Most women with XLH who are on active therapy at the time of conception are continued on treatment throughout the pregnancy with vigilant monitoring of urinary calcium-to-creatinine ratios to detect hypercalciuria early in order to modify treatment accordingly. Those individuals who are not on therapy at the time of conception are generally not started on treatment during pregnancy.</p>
        </sec>
        <sec id="rickets-xlh.Therapies_Under_Investigatio">
          <title>Therapies Under Investigation</title>
          <p>Currently, a novel therapeutic agent KRN23 is under investigation for XLH. This is a recombinant human monoclonal antibody targeting FGF23 (see <xref ref-type="sec" rid="rickets-xlh.Molecular_Genetics">Molecular Genetics</xref>). A randomized trial of a single dose of KRN23 has shown an increase in the renal tubular threshold for phosphate reabsorption (TmP/GFR) and an increase in serum Pi and 1,25(OH)<sub>2</sub>D compared with placebo [<xref ref-type="bibr" rid="rickets-xlh.REF.carpenter.2014.1587">Carpenter et al 2014</xref>]. A second study in adults looking at monthly dosing of KRN23 for 16 months demonstrated increases in serum phosphate, TmP/GFR, and 1,25 (OH)2D3 [<xref ref-type="bibr" rid="rickets-xlh.REF.imel.2015.2565">Imel et al 2015</xref>]. Analysis from quality of life testing during the first four months of the trial showed improvements in physical functioning and stiffness [<xref ref-type="bibr" rid="rickets-xlh.REF.ruppe.2016.158">Ruppe et al 2016</xref>]. Phase II studies in adults and children with XLH are ongoing.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="rickets-xlh.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="rickets-xlh.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>X-linked hypophosphatemia (XLH) is inherited in an X-linked dominant manner.</p>
        </sec>
        <sec id="rickets-xlh.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Male proband</p>
              <list list-type="bullet">
                <list-item>
                  <p>The father of an affected male will not have the disorder nor will he be hemizygous for the <italic toggle="yes">PHEX</italic> pathogenic variant; therefore, he does not require further evaluation/testing.</p>
                </list-item>
                <list-item>
                  <p>If a male is the only affected family member (i.e., a simplex case), the mother may be heterozygous for the pathogenic variant or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant. Molecular genetic testing is recommended for the mother of a male proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</p>
                </list-item>
                <list-item>
                  <p>In a family with more than one affected individual, the mother of an affected male is an obligate heterozygote and may have clinical findings. Note: If the mother of a male proband has more than one affected child and no other affected relatives and if the <italic toggle="yes">PHEX</italic> pathogenic variant cannot be detected in her leukocyte DNA, she most likely has germline mosaicism.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Female proband</p>
              <list list-type="bullet">
                <list-item>
                  <p>A female proband may have inherited the <italic toggle="yes">PHEX</italic> pathogenic variant from either her mother or her father, or the pathogenic variant may be <italic toggle="yes">de novo</italic>. Molecular genetic testing is recommended for the parents of a female proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant</p>
                </list-item>
                <list-item>
                  <p>If the pathogenic variant found in a female proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. Somatic and germline mosaicism has been reported in a father who transmitted the <italic toggle="yes">PHEX</italic> pathogenic variant to only one of his two daughters [<xref ref-type="bibr" rid="rickets-xlh.REF.goji.2006.365">Goji et al 2006</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until biochemical or molecular genetic testing is done on at-risk relatives [<xref ref-type="bibr" rid="rickets-xlh.REF.gaucher.2009.401">Gaucher et al 2009</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the genetic status of the parents:</p>
              <list list-type="bullet">
                <list-item>
                  <p>If the father of the proband has a <italic toggle="yes">PHEX</italic> pathogenic variant, he will transmit the disease to all of his daughters (who will be affected) and none of his sons.</p>
                </list-item>
                <list-item>
                  <p>If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Offspring who inherit the pathogenic variant will be affected.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the pathogenic variant cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental germline mosaicism. Somatic and germline mosaicism has been reported in a father who transmitted the <italic toggle="yes">PHEX</italic> pathogenic variant to only one of his two daughters [<xref ref-type="bibr" rid="rickets-xlh.REF.goji.2006.365">Goji et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Affected males transmit the <italic toggle="yes">PHEX</italic> pathogenic variant to:</p>
          <list list-type="bullet">
            <list-item>
              <p>All of their daughters, who will be heterozygotes and will be affected;</p>
            </list-item>
            <list-item>
              <p>None of their sons.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a female proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Affected females pass the <italic toggle="yes">PHEX</italic> pathogenic variant to 50% of their offspring.</p>
            </list-item>
            <list-item>
              <p>Male and female offspring who inherit the pathogenic variant will be affected.</p>
            </list-item>
          </list>
        </sec>
        <sec id="rickets-xlh.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p>Note: Molecular genetic testing may be able to identify the family member in whom a <italic toggle="yes">de novo</italic> pathogenic variant occurred, information that could help determine the genetic risk status of the extended family.</p>
          <p>See Management, <xref ref-type="sec" rid="rickets-xlh.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="rickets-xlh.Prenatal_Testing_and_Preimpl">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">PHEX</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="rickets-xlh.Resources">
        <title>Resources</title>
      </sec>
      <sec id="rickets-xlh.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="rickets-xlh.Molecular_Genetic_Pathogenes">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The function of the protein produced by <italic toggle="yes">PHEX</italic> is unknown. It is expressed predominantly in bones and teeth in osteoblasts, osteocytes, and odontoblasts. The structure of the protein suggests that it is an endopeptidase; however, the substrate for its proteolytic activity is unknown.</p>
          <p>Pathogenic variants in <italic toggle="yes">PHEX</italic> lead to increased serum levels of FGF23 [<xref ref-type="bibr" rid="rickets-xlh.REF.jonsson.2003.1656">Jonsson et al 2003</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.weber.2003.1227">Weber et al 2003</xref>]. The etiology of this increase is not understood as no direct link has been demonstrated between <italic toggle="yes">PHEX</italic> and FGF23. FGF23, which is produced by bone lineage cells, causes hypophosphatemia through internalization of the sodium-phosphate IIa and IIc cotransporters from the renal proximal tubule, leading to a decrease in phosphate reabsorption by the kidney and phosphate wasting [<xref ref-type="bibr" rid="rickets-xlh.REF.segawa.2007.f769">Segawa et al 2007</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.gattineni.2009.f282">Gattineni et al 2009</xref>]. Additionally, FGF23 causes downregulation of the renal 1 &#x003b1; hydroxylase enzyme and upregulation of the 24 hydroxylase enzyme leading to impaired 1,25(OH)<sub>2</sub> vitamin D synthesis and increased degradation [<xref ref-type="bibr" rid="rickets-xlh.REF.shimada.2004.429">Shimada et al 2004</xref>]. This dual defect in phosphate metabolism leads to poor bone mineralization and fractures.</p>
          <p>It has also been hypothesized that pathogenic variants in <italic toggle="yes">PHEX</italic> lead to an increase in direct inhibitors to bone mineralization, referred to as minhibins. The identification and the mechanism of action of these minhibins are unknown; it has been proposed that proteins containing protease-resistant acidic serine-aspartate-rich motif (ASARM peptide) such as those found in MEPE, DMP1, and OPN may play a role [<xref ref-type="bibr" rid="rickets-xlh.REF.addison.2008.1638">Addison et al 2008</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.martin.2008.1757">Martin et al 2008</xref>, <xref ref-type="bibr" rid="rickets-xlh.REF.david.2011.f783">David et al 2011</xref>] in the mineralization defect seen in XLH. The role of this bone-kidney axis in phosphate homeostasis and bone mineralization is an area of ongoing research.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">PHEX</italic> comprises 22 exons; the transcript length is 2861 bp (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000444.4">NM_000444.4</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="rickets-xlh" object-id="rickets-xlh.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> Pathogenic variants include missense and nonsense variants, deletions, small intra-exon insertions and deletions, duplications, and splice site variants. Pathogenic variants have been reported in every exon, multiple different intronic splice sites, and the 5' UTR. To date nearly 300 pathogenic variants have been described. The <italic toggle="yes">PHEX</italic> database (see <related-object source-id="gene" document-id="rickets-xlh" object-id="rickets-xlh.molgen.TA">Table A</related-object>, <bold>Locus Specific</bold>) is dedicated to maintaining information about nucleotide variation found in <italic toggle="yes">PHEX</italic>.</p>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">PHEX</italic> codes for a 749-amino acid protein (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000435.3">NP_000435.3</ext-link>). Although there have been many possible targets for the endopeptidase activity of <italic toggle="yes">PHEX,</italic> its substrate has yet to be discovered. The protein is expressed primarily in cells of bone lineage including osteoblasts, osteocytes, and odontoblasts &#x02013; leading to its importance in phosphate regulation and mineralization of these tissues. While <italic toggle="yes">PHEX</italic> is expressed primarily in cells of bone and teeth lineage, the main protein effects on renal phosphate wasting and impaired vitamin D metabolism occur in the kidney.</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">PHEX</italic> are considered loss-of-function variants. As the function of <italic toggle="yes">PHEX</italic> is unknown, little is known about the function of the abnormal gene product.</p>
        </sec>
      </sec>
      <sec id="rickets-xlh.References">
        <title>References</title>
        <sec id="rickets-xlh.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="rickets-xlh.Literature_Cited.reflist0">
            <ref id="rickets-xlh.REF.addison.2008.1638">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Addison</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loisel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crine</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKee</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <article-title>MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.</article-title>
                <source>J Bone Miner Res.</source>
                <year>2008</year>
                <volume>23</volume>
                <fpage>1638</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">18597632</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.alon.2008.658">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alon</surname>
                    <given-names>US</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy-Olomucki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>WV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stubbs</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarles</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.</article-title>
                <source>Clin J Am Soc Nephrol.</source>
                <year>2008</year>
                <volume>3</volume>
                <fpage>658</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">18256372</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.baroncelli.2006.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baroncelli</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angiolini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ninni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saggese</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuca</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence and pathogenesis of dental and periodontal lesions in children with X-linked hypophosphatemic rickets.</article-title>
                <source>Eur J Paediatr Dent.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>61</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16842025</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.becknielsen.2009.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beck-Nielsen</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brock-Jacobsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gram</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brixen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>TK</given-names>
                  </name>
                </person-group>
                <article-title>Incidence and prevalence of nutritional and hereditary rickets in southern Denmark.</article-title>
                <source>Eur J Endocrinol.</source>
                <year>2009</year>
                <volume>160</volume>
                <fpage>491</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19095780</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.becknielsen.2010.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beck-Nielsen</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brusgaard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brixen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brock-Jacobsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulsen</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vestergaard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ralston</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albagha</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haubek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gj&#x000f8;rup</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintze</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heickendorff</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hjelmborg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gram</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Phenotype presentation of hypophosphatemic rickets in adults.</article-title>
                <source>Calcif Tissue Int.</source>
                <year>2010</year>
                <volume>87</volume>
                <fpage>108</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">20524110</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.boukpessi.2006.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boukpessi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Septier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garabedian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussain-Miller</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Dentin alteration of deciduous teeth in human hypophosphatemic rickets.</article-title>
                <source>Calcif Tissue Int.</source>
                <year>2006</year>
                <volume>79</volume>
                <fpage>294</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">17115324</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.brownstein.2008.3455">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brownstein</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adler</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson-Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iijima</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabeshima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reyes-Mugica</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <article-title>A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2008</year>
                <volume>105</volume>
                <fpage>3455</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18308935</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.carpenter.2011.1381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imel</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jan de Beur</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insogna</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <article-title>A clinician's guide to X-linked hypophosphatemia.</article-title>
                <source>J Bone Miner Res.</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>1381</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21538511</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.carpenter.2014.1587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imel</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruppe</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klausner</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wooddell</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Humphrey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insogna</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peacock</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.</article-title>
                <source>J Clin Invest.</source>
                <year>2014</year>
                <volume>124</volume>
                <fpage>1587</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">24569459</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.clausmeyer.2009.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clausmeyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hesse</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemens</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreuzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker-Rose</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spital</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raue</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of the PHEX gene: novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets.</article-title>
                <source>Calcif Tissue Int.</source>
                <year>2009</year>
                <volume>85</volume>
                <fpage>211</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">19513579</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.connor.2015.3625">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Connor</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olear</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insogna</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sterpka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubrow</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                </person-group>
                <article-title>Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2015</year>
                <volume>100</volume>
                <fpage>3625</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">26176801</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.david.2011.f783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedge</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drezner</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowe</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <article-title>ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.</article-title>
                <source>Am J Physiol Renal Physiol.</source>
                <year>2011</year>
                <volume>300</volume>
                <fpage>F783</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">21177780</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.davies.1981.595">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanbury</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>The rheumatic manifestations of metabolic bone disease.</article-title>
                <source>Clin Rheum Dis.</source>
                <year>1981</year>
                <volume>7</volume>
                <fpage>595</fpage>
                <lpage>646</lpage>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.dixon.1998.3615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christie</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wooding</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trump</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grieff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gertner</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidtke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlessinger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of PHEX gene in X-linked hypophosphatemia.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>1998</year>
                <volume>83</volume>
                <fpage>3615</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">9768674</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.econs.1997.674">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McEnery</surname>
                    <given-names>PT</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>1997</year>
                <volume>82</volume>
                <fpage>674</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">9024275</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.feng.2006.1310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>JQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rios</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drezner</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarles</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonewald</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KE</given-names>
                  </name>
                </person-group>
                <article-title>Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.</article-title>
                <source>Nat Genet.</source>
                <year>2006</year>
                <volume>38</volume>
                <fpage>1310</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17033621</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.folpe.2004.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Folpe</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanburg-Smith</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billings</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisceglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inwards</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jan de Beur</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mentzel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montgomery</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miettinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reith</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connell</surname>
                    <given-names>JX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweet</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinh</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wold</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wehrli</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaino</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>SW</given-names>
                  </name>
                </person-group>
                <article-title>Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.</article-title>
                <source>Am J Surg Pathol.</source>
                <year>2004</year>
                <volume>28</volume>
                <fpage>1</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">14707860</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.gattineni.2009.f282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gattineni</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bates</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Twombley</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwarakanath</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goetz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammadi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baum</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.</article-title>
                <source>Am J Physiol Renal Physiol.</source>
                <year>2009</year>
                <volume>297</volume>
                <fpage>F282</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19515808</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.gaucher.2009.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaucher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walrant-Debray</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esterle</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garab&#x000e9;dian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jehan</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.</article-title>
                <source>Hum Genet.</source>
                <year>2009</year>
                <volume>125</volume>
                <fpage>401</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19219621</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.goji.2006.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadewa</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishio</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2006</year>
                <volume>91</volume>
                <fpage>365</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">16303832</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.hardy.1989.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <article-title>X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features.</article-title>
                <source>Radiology.</source>
                <year>1989</year>
                <volume>171</volume>
                <fpage>403</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">2539609</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.hoffman.2005.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jueppner</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deyoung</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'dorisio</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Given</surname>
                    <given-names>KS</given-names>
                  </name>
                </person-group>
                <article-title>Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2005</year>
                <volume>134</volume>
                <fpage>233</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15742370</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.holm.1997.790">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunkel</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1997</year>
                <volume>60</volume>
                <fpage>790</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9106524</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.holm.2001.3889">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mason</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowell</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2001</year>
                <volume>86</volume>
                <fpage>3889</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">11502829</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.ichikawa.2008.663">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ichikawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traxler</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estwick</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorenson</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imel</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets.</article-title>
                <source>Bone.</source>
                <year>2008</year>
                <volume>43</volume>
                <fpage>663</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18625346</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.imel.2015.2565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imel</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruppe</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klausner</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergeire</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Humphrey</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glorieux</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portale</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insogna</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peacock</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                </person-group>
                <article-title>prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2015</year>
                <volume>100</volume>
                <fpage>2565</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">25919461</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.jehan.2008.4672">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jehan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaucher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walrant-Debray</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahlou</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinding</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e9;chaux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garab&#x000e9;dian</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2008</year>
                <volume>93</volume>
                <fpage>4672</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">18827005</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.jonsson.2003.1656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zahradnik</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imanishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koshiyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ljunggren</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oba</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyauchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavigne</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000fc;ppner</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.</article-title>
                <source>N Engl J Med.</source>
                <year>2003</year>
                <volume>348</volume>
                <fpage>1656</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">12711740</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.kinoshita.2014.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukumoto</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia.</article-title>
                <source>Bone.</source>
                <year>2014</year>
                <volume>67</volume>
                <fpage>145</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">25026495</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.levylitan.2010.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levy-Litan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershkovitz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avizov</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leventhal</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bercovich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chalifa-Caspi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buriakovsky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadad</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goding</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parvari</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>86</volume>
                <fpage>273</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20137772</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.lockitch.1988.1622">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lockitch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halstead</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albersheim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacCallum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quigley</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer.</article-title>
                <source>Clin Chem.</source>
                <year>1988</year>
                <volume>34</volume>
                <fpage>1622</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">3402068</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.lorenzdepiereux.2006.1248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorenz-Depiereux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastepe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benet-Pag&#x000e8;s</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amyere</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagenstaller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Barth</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badenhoop</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaiser</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rittmaster</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shlossberg</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivares</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loris</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glorieux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000fc;ppner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <article-title>DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.</article-title>
                <source>Nat Genet.</source>
                <year>2006</year>
                <volume>38</volume>
                <fpage>1248</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">17033625</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.lorenzdepiereux.2010.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorenz-Depiereux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnabel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiosano</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;usler</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <article-title>Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>86</volume>
                <fpage>267</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">20137773</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.martin.2008.1757">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurence</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lafer</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedge</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowe</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <article-title>Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.</article-title>
                <source>Endocrinology.</source>
                <year>2008</year>
                <volume>149</volume>
                <fpage>1757</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">18162525</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.meites.1989">
              <mixed-citation publication-type="book">Meites S, ed. <italic toggle="yes">Pediatric Clinical Chemistry: Reference (Normal) Values</italic>. 3 ed. Washington, DC: American Association for Clinical Chemistry Press; 1989.</mixed-citation>
            </ref>
            <ref id="rickets-xlh.REF.morey.2011.116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro-Feij&#x000f3;o</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barreiro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabanas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pombo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernabeu</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000ed;az-Grande</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rey-Cordo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariceta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rica</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nieto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilalta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vila-Cots</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aleixandre</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontalba</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soriano-Guill&#x000e9;n</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Sagredo</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Mi&#x000f1;aur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juaristi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Pardos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Peinado</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mill&#x000e1;n</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medeira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moldovan</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loidi</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type.</article-title>
                <source>BMC Med Genet.</source>
                <year>2011</year>
                <volume>12</volume>
                <fpage>116</fpage>
                <pub-id pub-id-type="pmid">21902834</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.novais.2006.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Novais</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <article-title>Hypophosphatemic rickets: the role of hemiepiphysiodesis.</article-title>
                <source>J Pediatr Orthop.</source>
                <year>2006</year>
                <volume>26</volume>
                <fpage>238</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">16557142</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.omalley.1988.528">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O'Malley</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsden</surname>
                    <given-names>RT</given-names>
                  </name>
                </person-group>
                <article-title>The petrous temporal bone and deafness in X-linked hypophosphataemic osteomalacia.</article-title>
                <source>Clin Radiol.</source>
                <year>1988</year>
                <volume>39</volume>
                <fpage>528</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">3180671</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.owen.2009.237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habeb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichikawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorenson</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheetham</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Discordance for X-linked hypophosphataemic rickets in identical twin girls.</article-title>
                <source>Horm Res.</source>
                <year>2009</year>
                <volume>71</volume>
                <fpage>237</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">19258716</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.payne.1998.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Payne</surname>
                    <given-names>RB</given-names>
                  </name>
                </person-group>
                <article-title>Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation.</article-title>
                <source>Ann Clin Biochem.</source>
                <year>1998</year>
                <volume>35</volume>
                <fpage>201</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9547891</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.petje.2008.3078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Petje</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meizer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aigner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grill</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Deformity correction in children with hereditary hypophosphatemic rickets.</article-title>
                <source>Clin Orthop Relat Res.</source>
                <year>2008</year>
                <volume>466</volume>
                <fpage>3078</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">18841431</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.polisson.1985.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polisson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khoury</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrell</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyles</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrelson</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drezner</surname>
                    <given-names>MK</given-names>
                  </name>
                </person-group>
                <article-title>Calcification of entheses associated with X-linked hypophosphatemic osteomalacia.</article-title>
                <source>N Engl J Med.</source>
                <year>1985</year>
                <volume>313</volume>
                <fpage>1</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">4000222</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.popowska.2001.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Popowska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronicka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su&#x00142;ek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowi&#x00144;ska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rump</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arasimowicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewska-Walasek</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>X-linked hypophosphatemia in Polish patients. 2. Analysis of clinical features and genotype-phenotype correlation.</article-title>
                <source>J Appl Genet.</source>
                <year>2001</year>
                <volume>42</volume>
                <fpage>73</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">14564066</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.pronicka.2004.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pronicka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Popowska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowi&#x00144;ska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arasimowicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebiedowski</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Anthropometric characteristics of X-linked hypophosphatemia.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>126A</volume>
                <fpage>141</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15057978</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.riminucci.2003.683">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riminucci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedarko</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corsi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waguespack</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannon</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianco</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehron Robey</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.</article-title>
                <source>J Clin Invest.</source>
                <year>2003</year>
                <volume>112</volume>
                <fpage>683</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12952917</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.ruppe.2011.312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruppe</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brosnan</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Au</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>PX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dominguez</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Northrup</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <year>2011</year>
                <volume>74</volume>
                <fpage>312</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21050253</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.ruppe.2016.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruppe</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imel</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klausner</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergeire</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Humphrey</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glorieux</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portale</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insogna</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peacock</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>TO</given-names>
                  </name>
                </person-group>
                <article-title>Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia.</article-title>
                <source>Bone Rep.</source>
                <year>2016</year>
                <volume>5</volume>
                <fpage>158</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">28326356</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.sabbagh.2014">
              <mixed-citation publication-type="book">Sabbagh Y, Tenenhouse HS, Econs MJ, Auricchio A. Mendelian hypophosphatemias. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> New York, NY: McGraw-Hill. Chap 197. 2014.</mixed-citation>
            </ref>
            <ref id="rickets-xlh.REF.segawa.2007.f769">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onitsuka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiozawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aranami</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furutani</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomoe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwahata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabeshima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice.</article-title>
                <source>Am J Physiol Renal Physiol.</source>
                <year>2007</year>
                <volume>292</volume>
                <fpage>F769</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">16985213</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.shimada.2004.429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakahara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.</article-title>
                <source>J Bone Miner Res.</source>
                <year>2004</year>
                <volume>19</volume>
                <fpage>429</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">15040831</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.song.2007.981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>SC</given-names>
                  </name>
                </person-group>
                <article-title>PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets.</article-title>
                <source>J Korean Med Sci.</source>
                <year>2007</year>
                <volume>22</volume>
                <fpage>981</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18162710</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.song.2006.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soma Raju</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suh</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <article-title>Deformity correction by external fixation and/or intramedullary nailing in hypophosphatemic rickets.</article-title>
                <source>Acta Orthop.</source>
                <year>2006</year>
                <volume>77</volume>
                <fpage>307</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16752295</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.vega.2016.694">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vega</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opalak</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harshbarger</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fearon</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritter</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Hypophosphatemic rickets and craniosynostosis: a multicenter case series.</article-title>
                <source>J Neurosurg Pediatr.</source>
                <year>2016</year>
                <volume>17</volume>
                <fpage>694</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">26824597</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.vera.1997.710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vera</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cure</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naso</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelven</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worsham</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roof</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Resnick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salinas</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacult</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Paraplegia due to ossification of ligamenta flava in X-linked hypophosphatemia. A case report.</article-title>
                <source>Spine.</source>
                <year>1997</year>
                <volume>22</volume>
                <fpage>710</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9089946</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.walton.1975.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walton</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bijvoet</surname>
                    <given-names>OL</given-names>
                  </name>
                </person-group>
                <article-title>Nomogram for derivation of renal threshold phosphate concentration.</article-title>
                <source>Lancet.</source>
                <year>1975</year>
                <volume>2</volume>
                <fpage>309</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">50513</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.weber.2003.1227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Indridason</surname>
                    <given-names>OS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarles</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>Serum FGF23 levels in normal and disordered phosphorus homeostasis.</article-title>
                <source>J Bone Miner Res.</source>
                <year>2003</year>
                <volume>18</volume>
                <fpage>1227</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">12854832</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.white.2005.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabral</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishburn</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichikawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fields</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLellan</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeown</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ornitz</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2005</year>
                <volume>76</volume>
                <fpage>361</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15625620</pub-id>
              </element-citation>
            </ref>
            <ref id="rickets-xlh.REF.zivi_njak.2011.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zivi&#x0010d;njak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnabel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billing</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staude</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filler</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Querfeld</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schumacher</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyper</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e4;mswig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haffner</surname>
                    <given-names>D</given-names>
                  </name>
                  <collab>Hypophosphatemic Rickets Study Group of Arbeitsgemeinschaft f&#x000fc;r P&#x000e4;diatrische Endokrinologie and Gesellschaft f&#x000fc;r P&#x000e4;diatrische Nephrologie</collab>
                </person-group>
                <article-title>Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>223</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">21120538</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="rickets-xlh.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="rickets-xlh.Author_Notes">
          <title>Author Notes</title>
          <p>Dr. Mary Ruppe is an endocrinologist who specializes in the treatment of adult and pediatric patients with metabolic bone disease. She oversees the pediatric rickets clinic at the Shriners Hospital in Houston, TX and runs a metabolic bone clinic at The Methodist Hospital in Houston, TX. She is currently the local site principal investigator for several clinical trials on the treatment of XLH and conducts a large cohort study evaluating the clinical regulators of FGF23 in XLH.</p>
        </sec>
        <sec id="rickets-xlh.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>13 April 2017 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 October 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 September 2012 (cd) Revision: multi-gene panels for hypophosphatemic rickets available clinically</p>
            </list-item>
            <list-item>
              <p>9 February 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>1 September 2011 (mr) Initial submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="rickets-xlh.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Nomogram from <xref ref-type="bibr" rid="rickets-xlh.REF.walton.1975.309">Walton &#x00026; Bijvoet [1975]</xref> for calculation of the tubular resorption of phosphate corrected for glomerular filtration rate (TmP/GFR) utilizing the plasma phosphate concentration and the calculated tubular resorption of phosphate: 1- (urinary phosphate x serum creatinine)/(serum phosphate x urinary creatinine)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rickets-xlh-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
